-+ 0.00%
-+ 0.00%
-+ 0.00%

IBIO INITIATES NON-HUMAN PRIMATE STUDY OF FIRST-IN-CLASS ACTIVIN E ANTIBODY FOLLOWING POSITIVE PRECLINICAL DATA DEMONSTRATING PREVENTION IN WEIGHT REGAIN AFTER GLP-1 TREATMENT

Reuters·06/16/2025 11:00:01

Please log in to view news